F-1 (Shenyang Pharmaceutical University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameF-1 (Shenyang Pharmaceutical University)
Drug Alias NameF-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsAdrenergic receptors alpha-1Serotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsHypertensionProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenyang Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsHypertensionProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A